TCT 823: Association Between Sodium-Glucose Co-Transporter 2 Inhibitor Use and Renal Function After Transcatheter Aortic Valve Replacement: A Retrospective Matched Cohort Analysis

TCT 828: Natural History of Coronary Artery Disease After Transcatheter Aortic Valve Implantation

TCT 132: Impact of Comorbid Heart Failure With Reduced Ejection Fraction (HFrEF) in the Development of Arrhythmias Among Patients Hospitalized for Transcatheter Aortic Valve Replacement (TAVR)

TCT 128: TAVI/TAVR Device Capable of Heart Rhythm Pacing & Resynchronization Therapy

Heart Team Discussion: Selecting the Optimal Valve

Navitor Vision Overview

Heart Team Discussion: Lifetime Management Considerations

Key Take-Away Messages

TCT 906: Facilitated Transfemoral Versus Alternative Access Transcatheter Aortic Valve Replacement in Patients With Peripheral Vascular Disease: Intra-Procedural and 30-Day Outcomes

Navitor Vision Valve Case